Applied Proteomics DiscernDx to Use Applied Proteomics Assets to Explore New Dx Approaches Premium The API assets could enable more data-intensive, machine learning-based approaches to healthcare, said a principal at DiscernDx investor Khosla Ventures. Applied Proteomics Sells Assets to DiscernDx for $1.85M DiscernDx, which is backed by Khosla Ventures, stepped in to purchase API's assets after lender Square 1 Bank asserted a lien on the company late last year. Applied Proteomics Looking to Outsource Sales Operations, Expand Assay Development Premium The firm is looking for outside partners to tackle test commercialization as it begins to bring its second-generation colorectal cancer assay to market. Applied Proteomics Releasing Second-Gen Colon Cancer Test; Exploring Dried Blood Spots Premium The test, which the company aims to launch in the next few months, offers a boost in specificity compared to its existing SimpliPro Colon proteomic test. Applied Proteomics Encouraged by Early Sales of CRC Test Premium Company officials said that they have seen favorable reorder rates and coverage decisions since launching the 11-protein colorectal cancer test in late 2015. Jun 26, 2015 Applied Proteomics Prepping ELISA Version of CRC Test for Near-Term Release Premium Oct 9, 2013 Applied Proteomics, DKFZ to Collaborate on Cancer MDx Aug 23, 2013 API Closes on $28M Round Supporting Development of Colorectal Test, Biomarker Discovery Efforts Premium Aug 23, 2013 People in the News: Thomas Bachmann, Joseph Eggler, and More Premium Aug 20, 2013 Applied Proteomics Closes $28M Series C Round Jun 28, 2013 Slow Sales Leave Some Proteomics Dx Firms Questioning Value of Large Clinical Lab Deals Premium May 10, 2013 GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic Premium Mar 29, 2013 Changing Course, Applied Proteomics to Offer Colon Test via Mass Spec Instead of Immunoassay Premium Mar 7, 2013 Agilent, Applied Proteomics Partner on Development of Mass Spec-based Protein Assays Feb 10, 2012 Applied Proteomics Snags $22.5M in Funding; Aims to Optimize Mass Spec-Based Biomarker Discovery Premium Feb 10, 2012 People in the News: New Board Member, CEO at Applied Proteomics Premium Feb 7, 2012 Applied Proteomics Raises $22.5M, Moves to San Diego Dec 30, 2009 Applied Proteomics, ALS TDI Collaborating on Markers Breaking News Metastatic Tumor Subtypes Found With Expression Profiling Thermo Fisher Scientific Revenues Grow 7 Percent in Q4, 15 Percent in 2022 GenomeWeb Top 40 up 4 Percent in January, Following Broader Upswing LumiraDx Receives Notice From Nasdaq Over Missed Listing Requirement Sherlock Biosciences to Acquire Sense Biodetection The Scan Study Links Evolution of Longevity, Social Organization in Mammals With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals. Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival. CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system. Drug Response Variants May Be Distinct in Somatic, Germline Samples Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.